| 1782 |
1543: Mitochondrial Complex IV inhibition |
1545: Decrease in mitochondrial oxidative phosphorylation |
Dec 19, 2018 |
Mar 7, 2019 |
1 AOP
|
| 3555 |
1543: Mitochondrial Complex IV inhibition |
177: Increase, Mitochondrial dysfunction |
Aug 1, 2025 |
Aug 1, 2025 |
1 AOP
|
| 1783 |
1544: Mitochondrial Complex V inhibition |
1545: Decrease in mitochondrial oxidative phosphorylation |
Dec 19, 2018 |
Mar 7, 2019 |
1 AOP
|
| 2193 |
1816: Mitochondrial dysfunction EMPTY |
1817: Apoptotic cell death |
Nov 2, 2020 |
Nov 2, 2020 |
None
|
| 2195 |
1816: Mitochondrial dysfunction EMPTY |
1815: Increase, ER stress |
Nov 2, 2020 |
Nov 2, 2020 |
None
|
| 2499 |
1816: Mitochondrial dysfunction EMPTY |
1392: Increase, Oxidative Stress |
Oct 26, 2021 |
Oct 26, 2021 |
1 AOP
|
| 2932 |
1816: Mitochondrial dysfunction EMPTY |
2144: Impaired insulin signaling |
May 25, 2023 |
May 25, 2023 |
None
|
| 3043 |
1816: Mitochondrial dysfunction EMPTY |
1585: Proteasomal dysfunction |
Sep 14, 2023 |
Sep 14, 2023 |
None
|
| 188 |
178: Mitochondrial electron transport chain, disrupted |
40: Mitochondrial ATP production, decreased |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 3493 |
178: Mitochondrial electron transport chain, disrupted |
1115: Increase, ROS |
Feb 25, 2025 |
Feb 25, 2025 |
1 AOP
|
| 1942 |
1547: Mitochondrial Injury |
889: Proteostasis, impaired |
Jun 7, 2019 |
Jun 7, 2019 |
None
|
| 2715 |
1547: Mitochondrial Injury |
1825: Increase, Cell death |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 3049 |
1547: Mitochondrial Injury |
1812: Increase, Cyt c release |
Sep 14, 2023 |
Sep 14, 2023 |
1 AOP
|
| 3749 |
1195: modulation, Extracellular Matrix Composition |
870: Increase, Cell Proliferation |
Mar 25, 2026 |
Mar 25, 2026 |
1 AOP
|
| 3757 |
1195: modulation, Extracellular Matrix Composition |
344: Increase, Liver fibrosis |
Mar 25, 2026 |
Mar 25, 2026 |
1 AOP
|
| 603 |
598: modulation, sodium channel |
599: prolonged, Depolarization of neuronal membrane |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 802 |
801: modulation, Unknown |
802: Increased, HIF-1 alpha transcription |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2448 |
1912: Motile Cilia Number/Length, Decreased |
1908: CBF, Decreased |
Jul 23, 2021 |
Sep 28, 2021 |
1 AOP
|
| 1563 |
1425: Mu Opioid Receptor Agonism |
1426: Release of G Proteins |
Jun 8, 2017 |
Jun 8, 2017 |
2 AOPs
|
| 2443 |
1909: MCC, Decreased |
1250: Decreased lung function |
Jul 19, 2021 |
Mar 24, 2023 |
3 AOPs
|
| 2445 |
1910: Mucus Viscosity, Increased |
1908: CBF, Decreased |
Jul 19, 2021 |
Aug 2, 2021 |
None
|
| 2446 |
1910: Mucus Viscosity, Increased |
1909: MCC, Decreased |
Jul 19, 2021 |
Aug 2, 2021 |
None
|
| 757 |
764: N/A, Ataxia, paralysis, or hyperactivity |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 88 |
75: N/A, Covalent binding to protein, possibly lysine residue |
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways |
Nov 29, 2016 |
Sep 24, 2020 |
None
|
| 1700 |
75: N/A, Covalent binding to protein, possibly lysine residue |
398: Activation, Dendritic Cells |
Dec 7, 2017 |
Sep 24, 2020 |
None
|